Clinical Trial Update: Adjuvant Chemotherapy for High Risk Stage I Lung Adenocarcinoma [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on adjuvant chemotherapy for high-risk stage I lung adenocarcinoma across Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Lung Cancer
• Lung Neoplasms

Snippet

Sponsor: Fudan University | Conditions: Lung Neoplasms | Phase 2, Phase 3 | Status: UNKNOWN